Robert Tansley Overview
- Firm
- Cambridge Innova...
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
6
- Med. Deal Size
-
- Med. Valuation
-
Robert Tansley General Information
Biography
Dr. Robert Tansley serves as a Partner at Cambridge Innovation Capital. He serves as Board Member at Sortera Bio. He also serves as a Board Member at T-Therapeutics. He also serves as a Board Member at Pretzel Therapeutics. After seven years working in hospital medicine, Robert worked in development and regulatory roles at Sanofi, the MHRA, and Roche. Robert then spent a decade at early-stage biotech companies including Arakis (sold to Sosei Inc), founder and Chief Executive Officer at Treague, founding Chief Executive Officer of the University of Copenhagen spin-out Avilex Pharma, and part of the founding management team of KalVista (Nasdaq: KALV). Robert qualified in medicine from UCL. He is a member of the Royal College of Obstetricians & Gynaecologists and the Faculty of Pharmaceutical Medicine and has an MBA from London Business School and an M.Phil in Biostatistics from the University of Cambridge. Robert manages CIC's investments in Abcodia, Carrick Therapeutics, CMR Surgical, Gyroscope, and Morphogen -IX. He served as a Board Member at Inivata & Roca Test. He served as a Board Member & Investor Director at PetMedix. He also serves as Chairman at Exvastat. He served as Investment Director at Exvastat.
Contact Information
Address
- 22 Station Road
- Cambridge CB1 2JD
- England, United Kingdom
Robert Tansley Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Cambridge Innovation Capital | Investor | Partner | Cambridge, United Kingdom | Venture Capital |
Robert Tansley Board Seats (6)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Carrick Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Dublin, Ireland | |
Exvastat | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Cambridge, United Kingdom | |
Microbiotica | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Cambridge, United Kingdom | |
Pretzel Therapeutics | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Waltham, MA | |
Sortera Bio | Biotechnology | Privately Held (no backing) | Corporation | United Kingdom |
Robert Tansley Lead Partner on Deals (21)
Robert Tansley has been the lead partner on 21 deals. Their latest deal was with T-Therapeutics, a drug discovery company. The deal was made for on 15-Nov-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
T-Therapeutics | 15-Nov-2023 | Early Stage VC (Series A) | Completed | Drug Discovery | Cambridge, United Kingdom | |
Pretzel Therapeutics | 12-Sep-2022 | Completed | Biotechnology | Waltham, MA | ||
Microbiotica | 07-Mar-2022 | Completed | Drug Discovery | Cambridge, United Kingdom | ||
Carrick Therapeutics | 03-Mar-2022 | Completed | Drug Discovery | Dublin, Ireland | ||
PetMedix | 08-Sep-2021 | Completed | Drug Discovery | Cambridge, United Kingdom | ||
PetMedix | 19-May-2020 | Completed | Drug Discovery | Cambridge, United Kingdom | ||
STORM Therapeutics | 20-May-2019 | Completed | Drug Discovery | Cambridge, United Kingdom | ||
Congenica | 30-Apr-2019 | Completed | Decision/Risk Analysis | Cambridge, United Kingdom | ||
Morphogen-IX | 18-Dec-2018 | Early Stage VC (Series B) | Completed | Drug Discovery | Cambridge, United Kingdom | |
Microbiotica | 24-Oct-2018 | Early Stage VC | Completed | Drug Discovery | Cambridge, United Kingdom |
Robert Tansley Network (258)
Board Members (113)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Richard Sandberg | ROCA Test | Self | Cambridge, United Kingdom | |
Thomas Hulme | Carrick Therapeutics | GV | Dublin, Ireland | |
STORM Therapeutics | Cambridge Enterprise | Cambridge, United Kingdom | ||
Carrick Therapeutics | Cambridge Enterprise | Dublin, Ireland | ||
T-Therapeutics | F-Prime Capital | Cambridge, United Kingdom |
Portfolio Executives (137)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Alison Lloyd | T-Therapeutics | Head of Finance | 15-Nov-2023 | Cambridge, United Kingdom |
E-Chiang Lee Ph.D | T-Therapeutics | Executive Vice President, Research | 15-Nov-2023 | Cambridge, United Kingdom |
T-Therapeutics | Chairman | 15-Nov-2023 | Cambridge, United Kingdom | |
T-Therapeutics | Co-Founder, Board Member & Chief Executive Officer | 15-Nov-2023 | Cambridge, United Kingdom | |
Pretzel Therapeutics | Chief Executive Officer & Chairman | 12-Sep-2022 | Waltham, MA |
Fund Team Members (8)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Anne Horgan Ph.D | Cambridge Innovation Capital | Cambridge Innovation Capital I | Cambridge, United Kingdom |
Anne Horgan Ph.D | Cambridge Innovation Capital | Cambridge Innovation Capital II | Cambridge, United Kingdom |
Cambridge Innovation Capital | Cambridge, United Kingdom | ||
Cambridge Innovation Capital | Cambridge, United Kingdom | ||
Cambridge Innovation Capital | Cambridge, United Kingdom |
Robert Tansley Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Cambridge Innovation Capital I | Cambridge Innovation Capital | Venture Capital - Early Stage | Evergreen | |||||
Cambridge Innovation Capital II | Cambridge Innovation Capital | Venture - General | Closed | 2022 |
Robert Tansley FAQs
-
Who is Robert Tansley?
Dr. Robert Tansley serves as a Partner at Cambridge Innovation Capital.
-
How much does Robert Tansley typically invest?
Robert Tansley's median deal size is
. -
What is Robert Tansley’s main position?
Robert Tansley’s primary position is Partner.
-
What are the contact details for Robert Tansley?
Robert Tansley’s email address is ro
and his phone number is +44 01223 . -
How many active board seats does Robert Tansley hold?
Robert Tansley holds 6 board seats including Carrick Therapeutics, Exvastat, Microbiotica, Pretzel Therapeutics, and Sortera Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »